Vitamin Shoppe, Inc (VSI) Position Boosted by Schwab Charles Investment Management Inc.

Schwab Charles Investment Management Inc. raised its stake in shares of Vitamin Shoppe, Inc (NYSE:VSI) by 11.6% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 194,761 shares of the specialty retailer’s stock after buying an additional 20,166 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Vitamin Shoppe were worth $3,925,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the stock. Mason Street Advisors LLC boosted its stake in Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in Vitamin Shoppe during the first quarter valued at approximately $208,000. Arizona State Retirement System boosted its stake in Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock valued at $249,000 after buying an additional 100 shares in the last quarter. Stevens Capital Management LP boosted its stake in Vitamin Shoppe by 15.3% in the first quarter. Stevens Capital Management LP now owns 14,415 shares of the specialty retailer’s stock valued at $290,000 after buying an additional 1,909 shares in the last quarter. Finally, MARSHALL WACE ASIA Ltd acquired a new stake in Vitamin Shoppe during the first quarter valued at approximately $308,000.

Vitamin Shoppe, Inc (NYSE VSI) traded up 1.64% during trading on Wednesday, reaching $6.20. The company had a trading volume of 75,544 shares. Vitamin Shoppe, Inc has a 52-week low of $5.75 and a 52-week high of $28.41. The firm’s market capitalization is $144.03 million. The company has a 50-day moving average of $10.21 and a 200-day moving average of $15.62.

Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by $0.16. The firm had revenue of $304.84 million during the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The business’s revenue for the quarter was down 8.4% on a year-over-year basis. During the same quarter last year, the company earned $0.55 earnings per share. Analysts expect that Vitamin Shoppe, Inc will post $0.82 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Vitamin Shoppe, Inc (VSI) Position Boosted by Schwab Charles Investment Management Inc.” was posted by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/2824439/vitamin-shoppe-inc-vsi-position-boosted-by-schwab-charles-investment-management-inc.html.

VSI has been the subject of several recent analyst reports. TheStreet cut Vitamin Shoppe from a “c-” rating to a “d” rating in a report on Wednesday, August 9th. Barclays PLC reaffirmed an “equal weight” rating and issued a $13.00 price objective (down from $24.00) on shares of Vitamin Shoppe in a research note on Sunday, May 14th. Morgan Stanley raised Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price objective for the company in a research note on Thursday, May 11th. Zacks Investment Research raised Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 18th. Finally, ValuEngine downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Three analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $15.71.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe, Inc (NYSE:VSI).

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2017 Ticker Report. Google+.